A recent New York Times article describes the difficulties some pharmaceutical manufacturers are facing as they attempt to bring drugs to market that rely on specialized diagnostic testing to determine which patients may benefit.
A recent New York Times article describes the difficulties some pharmaceutical manufacturers are facing as they attempt to bring drugs to market that rely on specialized diagnostic testing to determine which patients may benefit.